News Today
Biocontrol's Diasensor Displayed At American Diabetes Association Annual Meeting
PITTSBURGH--(BUSINESS WIRE)--July 1, 1999--Biocontrol Technology Inc. (OTCBB:BICO - news) announced today that its Diasensor noninvasive glucose monitor was displayed at the recent meeting of the American Diabetes Association in San Diego, Calif. Currently marketed in the 15-country European Union, the Diasensor is the first commercially available painless noninvasive monitor for glucose measurements in people with diabetes.
To gain marketing approval in the United States, Biocontrol has begun a modular premarket approval (PMA) application to the FDA by submitting the first module on May 24, 1999. The FDA is expected to respond to Biocontrol within 90 days of the submission date. Additional information will be required to complete the full modular PMA.
The American Diabetes Association's annual meeting, which was held this year June 19 through June 22, attracts thousands of physicians, nurses, educators, scientists, suppliers and other miscellaneous attendees. David Purdy, Biocontrol's president, who attended the meeting, said that advances in noninvasive glucose testing were in evidence and that ''it was gratifying to our company to be the first manufacturer there that has received regulatory approval to market a truly noninvasive glucose monitor.'' The CE Mark, which permits the company to sell the devices in the European Union, was awarded to Biocontrol for the sensor in March 1998.
Biocontrol Technology has its corporate offices in Pittsburgh and is involved in the development and manufacture of biomedical devices and environmental products. Subsidiary Diasensor.com Inc., also located in Pittsburgh, markets the Diasensor. Diasensor.com owns the patent, marketing and distribution rights to the sensor while Biocontrol has the exclusive rights to the research and development and manufacturing of the sensor.
WEBSITE: www.bico.com
INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204
--------------------------------------------------------------------------------
Contact:
Biocontrol Technology Inc., Pittsburgh
Investors:
Diane McQuaide, 412/429-0673
Fax: 412/279-9690
or Media:
Susan Taylor, 412/429-0673
Fax: 412/279-5041
|
